Richard Pulik, CFO at Roivant Sciences Ltd. (ROIV), sold 553,462 shares at $22.39 ($12.4M) on 2025-12-23, disclosed to the SEC on 2025-12-29.
Open-market sale of $12.4M ROIV by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.39 | 146,731 | $3.3M | 26.5% |
| 2 | $22.39 | 146,731 | $3.3M | 26.5% |
| 3 | $22.45 | 260,000 | $5.8M | 47.0% |
| Total | $22.42 avg | 553,462 | $12.4M | 100% |